Summary: A Phase 2 randomized clinical trial demonstrates that a single 25 mg dose of psilocybin, combined with psychotherapeutic support, provides rapid, statistically significant, and clinically meaningful reduction in symptoms…
Tag: psychopharmacology
Brain-Stimulating Contact Lenses Match Prozac in Depression Study
Summary: Materials scientists have developed a “wearable, drug-free” contact lens capable of treating depression by delivering mild electrical signals through the retina. The study demonstrates that these specialized lenses are…
How Scientists Cracked the Ketamine Code for Depression
Summary: Ketamine has been a “miracle” for many with treatment-resistant depression, but its side effects and short duration have limited its use. Two new studies have “reverse engineered” exactly how…
SSRIs May Trigger Tinnitus – Neuroscience News
Summary: For millions of people, Selective Serotonin Reuptake Inhibitors (SSRIs) are a lifeline for managing depression and anxiety. However, a new study reveals a hidden cost: elevated serotonin can directly…
Blocking NOX-1 Extends Ketamine’s Effectiveness for Depression
Summary: Ketamine has been a miracle for the 30% of patients with treatment-resistant depression (TRD), lifting suicidal thoughts and heavy moods in hours rather than weeks. However, its “Achilles’ heel”…
ADHD Medication May Shield Against Psychosis
Summary: A major study has found that treating ADHD with stimulant medication during childhood may actually lower the long-term risk of developing serious psychotic disorders, such as schizophrenia. The research…
Healing Without the Hallucinations: The Next Generation of Psilocybin Therapy
Summary: While psilocybin is hailed as a breakthrough for depression and anxiety, many patients remain wary of the intense “trips” associated with the drug. Now, researchers have engineered modified versions…
Psychedelics Remodel Myelin to Heal PTSD
Summary: For years, scientists have focused on how psychedelics “rewire” neurons. But a groundbreaking study has found a “missing link” in long-term PTSD recovery: myelin remodeling. Researchers discovered that psilocybin…
Moving Beyond Dopamine to Treat Schizophrenia
Summary: Schizophrenia treatment has been dominated by dopamine-targeting drugs for decades, but these often fail to address the debilitating cognitive and negative symptoms of the disorder. A comprehensive review synthesizes…
Could an “Exercise Pill” Help Treat Depression?
Summary: It’s a cruel irony of mental health: exercise is a powerful antidepressant, yet depression often robs people of the motivation and energy required to move. A new paper proposes…
